PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanolic and methanolic extracts showed cytotoxic activity against human monocytic leukemia (THP-1) cells and MDA-MB-231 breast cancer cells [PMID: 27618154, 33072905].
Various organic leaf extracts demonstrated antiplasmodial activity against Plasmodium falciparum [PMID: 29491 la54].
Leaf extracts showed antibacterial activity against various strains including E. coli and P. aeruginosa [PMID: 20109237, 30899158]. In broiler chickens, methanol leaf extract provided hepatoprotective and cardioprotective effects against E. coli challenge [PMID: 38390080].
Essential oils exhibited nonselective antifungal activity against Colletotrichum species and Aspergillus species [PMID: 25127023, 25199920].
Evidence summary
PubMed sources
- 1.PMID: 17342614 (1985) — Volatile Constituents of Artemisia nilagirica. · Planta medica
- 2.PMID: 38390080 (2024) — Hepatoprotective and cardioprotective effect of Artemisia nilagirica leaf extract on E. coli challenged broiler chicken. · Heliyon
- 3.PMID: 25127023 (2014) — Chemical composition and biological effects of Artemisia maritima and Artemisia nilagirica essential oils from wild plants of western Himalaya. · Planta medica
- 4.PMID: 36296712 (2022) — Phytochemical Composition and In Vitro Antioxidant, Anti-Inflammatory, Anticancer, and Enzyme-Inhibitory Activities of Artemisia nilagirica (C.B. Clarke) Pamp. · Molecules (Basel, Switzerland)
- 5.PMID: 32663894 (2020)